Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

RSLS - ReShape Lifesciences Inc.


IEX Last Trade
0.1524
-0.008   -5.446%

Share volume: 699,809
Last Updated: Fri 30 Aug 2024 09:42:54 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$0.16
-0.01
-5.17%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
12%
Profitability 8%
Dept financing 11%
Liquidity 36%
Performance 10%
Company vs Stock growth
vs
Performance
5 Days
-5.79%
1 Month
-19.54%
3 Months
-35.63%
6 Months
-6.67%
1 Year
-83.32%
2 Year
-99.27%
Key data
Stock price
$0.15
P/E Ratio 
-0.52
DAY RANGE
N/A - N/A
EPS 
-$0.53
52 WEEK RANGE
$0.14 - $1.29
52 WEEK CHANGE
-$0.82
MARKET CAP 
4.731 M
YIELD 
N/A
SHARES OUTSTANDING 
29.387 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/06/2024
BETA 
1.13
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$458,760
AVERAGE 30 VOLUME 
$354,112
Company detail
CEO: Andrew Rasdal
Region: US
Website: http://www.obalon.com/
Employees: 50
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

reshape medical is a development-stage medical device manufacturer headquartered in southern california. the company is focused on the development of non-surgical weight loss devices that can be used as aids in the treatment of obese or overweight patients. there are millions of people looking for a solution to assist them in their battle to lose weight, but many are afraid of the risks of surgery. previously, few if any options existed between drugs for weight loss and invasive surgical restructuring of the anatomy. reshape medical intends to broaden the options and is developing less invasive devices for weight loss treatment.

Recent news